2023/01/31 17:17:38 | |
---|---|
Price | |
498.745 USD | |
Difference | 1.98% (9.66) |
ISIN | US0367521038 |
Symbol | ELV |
Exchange | NYSE |
Currency | USD |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 107,660 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | 498.18 USD (200) |
Ask (Ask size) | 498.97 USD (200) |
Open | 492.00 USD |
High | 508.78 USD |
Low | 490.50 USD |
Close (prev. day) | 489.08 USD |
VWAP | 500.223325 USD |
Volume (pcs) | 326,683 |
Trading volume | 163,493,782.62 |
Number of trades | 9,441 |
Last size | 100 |
Related Futures | 15 |
Related Options | - |
Date | Headline | Download | |
2023/01/30 |
![]() |
Global Equity Ratings |
![]() |
2023/01/09 |
![]() |
Global Equity Ratings |
![]() |
2023/01/09 |
![]() |
Global Strategy 1Q 2023 |
![]() |
2022/12/19 |
![]() |
Global Equity Ratings |
![]() |
2022/11/28 |
![]() |
Global Equity Ratings |
![]() |
2023/01/31 17:17:38 | |
---|---|
Price | |
498.745 USD | |
Difference | 1.98% (9.66) |
ISIN | US0367521038 |
Symbol | ELV |
Exchange | NYSE |
Currency | USD |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 107,660 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | 498.18 USD (200) |
Ask (Ask size) | 498.97 USD (200) |
Open | 492.00 USD |
High | 508.78 USD |
Low | 490.50 USD |
Close (prev. day) | 489.08 USD |
VWAP | 500.223325 USD |
Volume (pcs) | 326,683 |
Trading volume | 163,493,782.62 |
Number of trades | 9,441 |
Last size | 100 |
6m | 1Y | 3Y | |
Perf (%) | +2.51% | +10.63% | +83.94% |
Perf (abs.) | +11.98 | +46.99 | +223.19 |
Beta | 0.42 | 0.54 | 0.97 |
Volatility | 25.07 | 27.67 | 38.54 |
Ø price 5 days | Ø volume 5 days (pcs.) | 491.582 USD (1,312,131) |
Ø price 30 days | Ø volume 30 days (pcs.) | 492.429 USD (1,123,330) |
Ø price 100 days | Ø volume 100 days (pcs.) | 496.282 USD (1,083,540) |
Ø price 250 days | Ø volume 250 days (pcs.) | 487.460 USD (1,089,985) |
YTD High | date | 511.970 USD (2023/01/03) |
YTD Low | date | 464.640 USD (2023/01/06) |
52 Weeks High | date | 549.520 USD (2022/10/31) |
52 Weeks Low | date | 431.960 USD (2022/02/01) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Vienna Stock Exchange | 2023/01/31 | 09:05 | 451.80 EUR | 0.00 | 1 |
Tradegate | 2023/01/30 | 22:26 | 451.10 EUR | 0.00 | 3 |
Stuttgart | 2023/01/31 | 08:01 | 446.40 EUR | 0.00 | 1 |
NYSE | 2023/01/31 | 17:17 | 498.745 USD | 163.49 | 9,442 |
Munich | 2023/01/31 | 08:01 | 446.50 EUR | 0.00 | 1 |
London Stock Exchange | 2023/01/25 | 18:02 | 483.00 USD | 0.70 | 1 |
Frankfurt | 2023/01/31 | 09:01 | 447.05 EUR | 0.00 | 2 |
Duesseldorf | 2023/01/31 | 16:01 | 458.20 EUR | 0.00 | 9 |
Berlin | 2023/01/31 | 08:08 | 447.10 EUR | 0.00 | 1 |
BX Swiss | - | - | - | 0.00 | - |
ELEVANCE HEALTH INC. |
- - |
220 Virginia Avenue - 46204 Indianapolis |
Telefon: 1-800-331-1476 |
Fax: - |
E-mail: - |
Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. The firm supports consumers, families, and communities across the entire care journey, connecting them to the care, support, and resources they need to lead healthier lives. It offers health plans and clinical, behavioral, pharmacy, and complex-care solutions which promote whole health. The company was founded in 1944 and is headquartered in Indianapolis, IN. |
Elizabeth Tallett | Chairman of Board of Directors |
Bahija Jallal | Member of Board of Directors |
Ryan Schneider | Member of Board of Directors |
Antonio Neri | Member of Board of Directors |
Deanna Strable-Soethout | Member of Board of Directors |
Lewis Hay | Member of Board of Directors |
R. Clark | Member of Board of Directors |
Ramiro Peru | Member of Board of Directors |
Robert Dixon | Member of Board of Directors |
Susan DeVore | Member of Board of Directors |
Gail Boudreaux | Chairman of Managing Board |
Blair Todt | Member of Executive Committee |
Felicia F. Norwood | Member of Executive Committee |
Gloria McCarthy | Member of Executive Committee |
John Gallina | Member of Executive Committee |
Morgan Kendrick | Member of Executive Committee |
Peter D. Haytaian | Member of Executive Committee |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer